Lipids & metabolic liver disease

Insulin resistance assessed by estimated glucose disposal rate and risk of incident cardiovascular diseases among individuals without diabetes: findings from a nationwide, population based, prospective cohort study

Cardiovasc DiabetolPublished Prospective cohort study

Authors' conclusion

A lower level of eGDR was found to be associated with increased risk of incident CVD among non-diabetic participants. This suggests that eGDR may serve as a promising and preferable predictor and intervention target for CVD.

Study context

Population
Individuals without cardiovascular diseases (CVD) or DM with complete baseline estimated glucose disposal rate (eGDR) data, China Health and Retirement Longitudinal Study (CHARLS); mean age 58.2 ± 8.8 years, 54.1% female
Participants
5,512 individuals
Exposure
eGDR quartiles Q2–Q4 vs Q1
Outcome
Incident CVD
Follow-up
Median 79.4 months
Methodological detailsnationwide, population based
  • Nationwide
  • Population based

Main finding

As reported in the abstract

Incident CVD (multivariate adjusted)
Each group vs Q1Hazard ratio (95% CI)
Q2
0.88(0.76–1.02)
Q3
0.69(0.58–0.82)
Q4
0.66(0.56–0.79)
Incident CVD cases
1213
Per 1.0-SD increase in eGDR: 17% lower CVD risk, HR
0.83 (95% CI 0.78 - 0.89)

Observational data: associations, not effects.

Further findings

Incident heart disease and stroke cases

Heart disease cases
927
Stroke cases
391

Dose-response (restricted cubic spine (RCS))

Significant and linear relationship between eGDR and all outcomes
all P for non-linearity > 0.05

Effect modification by smoking status

Smoking status modified the association
P for interaction = 0.012

Mediation and prediction

Obesity partly mediated the association
Adding eGDR to the basic model considerably improved CVD prediction

Original publication

Insulin resistance assessed by estimated glucose disposal rate and risk of incident cardiovascular diseases among individuals without diabetes: findings from a nationwide, population based, prospective cohort study. Cardiovasc Diabetol. Published 6 June 2024. doi:10.1186/s12933-024-02256-5

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.